EE04700B1 - Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid - Google Patents
Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodidInfo
- Publication number
- EE04700B1 EE04700B1 EEP200100161A EEP200100161A EE04700B1 EE 04700 B1 EE04700 B1 EE 04700B1 EE P200100161 A EEP200100161 A EE P200100161A EE P200100161 A EEP200100161 A EE P200100161A EE 04700 B1 EE04700 B1 EE 04700B1
- Authority
- EE
- Estonia
- Prior art keywords
- processes
- slow
- preparation
- release
- active compound
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19842753A DE19842753A1 (de) | 1998-09-18 | 1998-09-18 | Agitationsunabhängige pharmazeutische Retardzubereitungen und Verfahren zu ihrer Herstellung |
PCT/EP1999/006882 WO2000016748A1 (de) | 1998-09-18 | 1999-09-17 | Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200100161A EE200100161A (et) | 2002-08-15 |
EE04700B1 true EE04700B1 (et) | 2006-10-16 |
Family
ID=7881376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200100161A EE04700B1 (et) | 1998-09-18 | 1999-09-17 | Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid |
Country Status (29)
Country | Link |
---|---|
US (1) | US6805881B1 (et) |
EP (1) | EP1113787B1 (et) |
JP (1) | JP2002526437A (et) |
KR (1) | KR100660072B1 (et) |
CN (1) | CN1178650C (et) |
AT (1) | ATE260645T1 (et) |
AU (2) | AU5861499A (et) |
BG (1) | BG105325A (et) |
BR (1) | BR9913839A (et) |
CA (1) | CA2344372C (et) |
DE (2) | DE19842753A1 (et) |
DK (1) | DK1113787T3 (et) |
EE (1) | EE04700B1 (et) |
ES (1) | ES2215404T3 (et) |
HK (1) | HK1040932B (et) |
HR (1) | HRP20010198A2 (et) |
HU (1) | HUP0103669A3 (et) |
ID (1) | ID28735A (et) |
IL (2) | IL141532A0 (et) |
NO (1) | NO20011211L (et) |
NZ (1) | NZ510563A (et) |
PL (1) | PL195543B1 (et) |
PT (1) | PT1113787E (et) |
RU (1) | RU2235540C2 (et) |
SK (1) | SK285099B6 (et) |
TR (1) | TR200100756T2 (et) |
UA (1) | UA73097C2 (et) |
WO (2) | WO2000016747A1 (et) |
ZA (1) | ZA200101485B (et) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19962924A1 (de) | 1999-12-24 | 2001-07-05 | Bayer Ag | Substituierte Oxazolidinone und ihre Verwendung |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
DE10129725A1 (de) * | 2001-06-20 | 2003-01-02 | Bayer Ag | Kombinationstherapie substituierter Oxazolidinone |
AR034813A1 (es) † | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
DE10300111A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
DE10355461A1 (de) | 2003-11-27 | 2005-06-23 | Bayer Healthcare Ag | Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung |
DE102004062475A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung |
BRPI0518396A2 (pt) | 2004-12-27 | 2008-11-18 | Eisai R&D Man Co Ltd | mÉtodo para estabilizaÇço de droga anti-demÊncia |
US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
EP1685841A1 (en) * | 2005-01-31 | 2006-08-02 | Bayer Health Care Aktiengesellschaft | Prevention and treatment of thromboembolic disorders |
DE102005012561B4 (de) | 2005-03-18 | 2008-06-19 | Christian Beer | Verfahren zum Betrieb eines Werkstück-Transfersystems |
DE102005045518A1 (de) * | 2005-09-23 | 2007-03-29 | Bayer Healthcare Ag | 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung |
DE102005047558A1 (de) * | 2005-10-04 | 2008-02-07 | Bayer Healthcare Ag | Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen |
PL1934208T3 (pl) | 2005-10-04 | 2011-09-30 | Bayer Ip Gmbh | Nowa polimorficzna postać 5-chloro-N-({ (5S)-2-okso-3-[4-( 3-okso-4-morfolinylo)-fenylo]-1,3-oksazolidyn-5-ylo}-metylo)-2-tiofenokarboksamidu |
DE102005047561A1 (de) | 2005-10-04 | 2007-04-05 | Bayer Healthcare Ag | Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung |
CN100448432C (zh) * | 2006-10-26 | 2009-01-07 | 徐竹青 | 高溶出度尼莫地平分散片的制备方法 |
DE102006051625A1 (de) * | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
US7952167B2 (en) * | 2007-04-27 | 2011-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Scribe line layout design |
PT2391345E (pt) * | 2009-01-28 | 2014-12-03 | Novartis Ag | Formulações galénicas compreendendo aliscireno |
US20100247646A1 (en) * | 2009-03-26 | 2010-09-30 | Ranbaxy Laboratories Limited | Extended release tablets of nisoldipine |
PL2554168T3 (pl) | 2010-03-29 | 2018-05-30 | Astellas Pharma Inc. | Kompozycja farmaceutyczna do kontrolowanego uwalniania |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5482525A (en) | 1977-12-13 | 1979-06-30 | Aisan Ind Co Ltd | Exhaust gas recirculation system |
US4226849A (en) * | 1979-06-14 | 1980-10-07 | Forest Laboratories Inc. | Sustained release therapeutic compositions |
US4327725A (en) | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4369172A (en) * | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US4449983A (en) | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
GB8514665D0 (en) * | 1985-06-11 | 1985-07-10 | Eroceltique Sa | Oral pharmaceutical composition |
DE3612212A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
DE3612211A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
DE3720757A1 (de) | 1987-06-24 | 1989-01-05 | Bayer Ag | Dhp-manteltablette |
DE3830353A1 (de) | 1988-09-07 | 1990-03-15 | Basf Ag | Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen |
JPH03145418A (ja) | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
DE69222847T3 (de) | 1991-04-16 | 2005-09-15 | Nippon Shinyaku Co., Ltd. | Verfahren zur herstellung einer festen dispersion |
DE4138513A1 (de) | 1991-11-23 | 1993-05-27 | Basf Ag | Feste pharmazeutische retardform |
DE4413350A1 (de) | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
SE9402422D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
FR2725624B1 (fr) | 1994-10-14 | 1997-01-17 | Jouveinal Inst Rech | Procede de preparation de formes pharmaceutiques a liberation controlee |
DE19504831A1 (de) | 1995-02-14 | 1996-09-05 | Basf Ag | Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose |
-
1998
- 1998-09-18 DE DE19842753A patent/DE19842753A1/de not_active Withdrawn
-
1999
- 1999-09-08 AU AU58614/99A patent/AU5861499A/en not_active Abandoned
- 1999-09-08 WO PCT/EP1999/006608 patent/WO2000016747A1/de active Application Filing
- 1999-09-17 DE DE59908764T patent/DE59908764D1/de not_active Expired - Lifetime
- 1999-09-17 AT AT99948770T patent/ATE260645T1/de not_active IP Right Cessation
- 1999-09-17 AU AU61918/99A patent/AU750617B2/en not_active Ceased
- 1999-09-17 NZ NZ510563A patent/NZ510563A/xx unknown
- 1999-09-17 EE EEP200100161A patent/EE04700B1/et not_active IP Right Cessation
- 1999-09-17 RU RU2001110355/15A patent/RU2235540C2/ru not_active IP Right Cessation
- 1999-09-17 PT PT99948770T patent/PT1113787E/pt unknown
- 1999-09-17 PL PL99346535A patent/PL195543B1/pl unknown
- 1999-09-17 BR BR9913839-5A patent/BR9913839A/pt not_active Application Discontinuation
- 1999-09-17 JP JP2000573709A patent/JP2002526437A/ja not_active Ceased
- 1999-09-17 CN CNB998110299A patent/CN1178650C/zh not_active Expired - Fee Related
- 1999-09-17 EP EP99948770A patent/EP1113787B1/de not_active Expired - Lifetime
- 1999-09-17 DK DK99948770T patent/DK1113787T3/da active
- 1999-09-17 ES ES99948770T patent/ES2215404T3/es not_active Expired - Lifetime
- 1999-09-17 IL IL14153299A patent/IL141532A0/xx not_active IP Right Cessation
- 1999-09-17 WO PCT/EP1999/006882 patent/WO2000016748A1/de active IP Right Grant
- 1999-09-17 KR KR1020017003495A patent/KR100660072B1/ko not_active IP Right Cessation
- 1999-09-17 US US09/787,229 patent/US6805881B1/en not_active Expired - Fee Related
- 1999-09-17 TR TR2001/00756T patent/TR200100756T2/xx unknown
- 1999-09-17 UA UA2001042576A patent/UA73097C2/uk unknown
- 1999-09-17 HU HU0103669A patent/HUP0103669A3/hu unknown
- 1999-09-17 ID IDW20010651A patent/ID28735A/id unknown
- 1999-09-17 CA CA002344372A patent/CA2344372C/en not_active Expired - Fee Related
- 1999-09-17 SK SK372-2001A patent/SK285099B6/sk unknown
-
2001
- 2001-02-20 IL IL141532A patent/IL141532A/en unknown
- 2001-02-22 ZA ZA200101485A patent/ZA200101485B/en unknown
- 2001-03-09 NO NO20011211A patent/NO20011211L/no not_active Application Discontinuation
- 2001-03-09 BG BG105325A patent/BG105325A/bg unknown
- 2001-03-16 HR HR20010198A patent/HRP20010198A2/hr not_active Application Discontinuation
-
2002
- 2002-04-11 HK HK02102756.8A patent/HK1040932B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04700B1 (et) | Segamisest sõltumatud toimeainet aeglustatult vabastavad mitmeosalised ravimvormid ja nende valmistamismeetodid | |
HK1031325A1 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
NO995006D0 (no) | Nye forbindelser | |
CA2427815A1 (en) | Controlled release hydrocodone formulations | |
YU35893A (sh) | Formulacije oksidona sa kontrolisanim otpuštanjem i njihova upotreba | |
ES2172239T3 (es) | Sistema osmotico de liberacion de farmacos. | |
BG104727A (en) | Pharmaceutical composition of topiramate | |
BR9405843A (pt) | Processo para reduzir perda óssea e uso de um composto | |
HUP0002296A2 (hu) | Sertralinsók és a sertralin elnyújtott felszabadulását biztosító dózisformák | |
BR9612291A (pt) | Forma de dosagem sólida bioadesiva | |
BR9916361A (pt) | Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia | |
BR0111868A (pt) | Composições farmacêuticas | |
HU9301672D0 (en) | Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents | |
FI955837A (fi) | Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi | |
HUT59316A (en) | Process for producing solid, orally administrable dosage forms comprising iphosphamide as active ingredient | |
UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
ZA944317B (en) | New phosphonosuccinic acid derivatives processes for the preparation thereof and pharmaceutical compositions containing them | |
MY133957A (en) | "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor" | |
TH43680A (th) | เกลือเชอร์ทราลีนและรูปแบบการใช้ที่มีการหน่วงการปลดปล่อยของเซอร์ทราลีน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
MM4A | Lapsed by not paying the annual fees |
Effective date: 20070917 |